Hvis der forekommer tegn på pulmonalt ødem, når inhaleret iloprost administreres hos patienter med pulmonal hypertension, bør muligheden for en associeret pulmonal veno- okklusiv sygdom overvejes.
Should signs of pulmonary oedema occur when inhaled iloprost is administered in patients with pulmonary hypertension, the possibility of associated pulmonary veno-occlusive disease should be considered.